Etonogestrel sustained release - Orbis Biosciences
Alternative Names: DARE 204/214; DARE-204; DARE-214; ORB 204; ORB 214Latest Information Update: 10 Sep 2024
At a glance
- Originator Orbis Biosciences
- Class Hormonal contraceptives; Norpregnanes; Phenanthrenes; Progesterone congeners; Small molecules
- Mechanism of Action Progesterone receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Pregnancy
Most Recent Events
- 10 Sep 2024 Etonogestrel sustained release is still in preclinical development for Pregnancy (Prevention) in USA (SC, Injection)
- 28 May 2024 No recent reports of development identified for preclinical development in Pregnancy(Prevention) in USA (SC, Injection)
- 07 Jul 2023 Dare Bioscience plans to initiate a phase I trial in Pregnancy